Prime Minister Howard announces $50 million injection for WEHI expansion

March 03, 2006

The Prime Minister, Mr John Howard, today announced a Commonwealth government contribution of $50 million towards a seven storey building expansion program. The project will double WEHI's floor space and substantially increase medical research capacity for the benefit of WEHI and other research institutions. The multi-million dollar construction project is expected to be finished within five years.

In a visit coinciding with the Institute's 90th anniversary, Mr Howard praised the many advances made in basic biomedical research over the decades and its impact on medicine and health.

Victorian Premier, Mr Steve Bracks, congratulated the Commonwealth for joining with the State government in supporting the expansion in WEHI's research capabilities, for the ultimate good of people around the world. The Victorian government pledged $50 million to the project in November 2005.

The Director of WEHI, Professor Suzanne Cory, said that the funding would enable substantial expansion of the Institute's research programs and enhance its capacity to translate discoveries in the laboratory more rapidly into the clinic.

"Cancer and infectious diseases will be a particular focus," said Professor Cory.

"Cancer kills more Australians than any other single cause and is the nation's biggest disease concern. One in three Australians develop cancer before the age of 75, and over a quarter will die from the disease. One third of cancer cases could be prevented - the remaining two-thirds must be more effectively treated. Therefore, there is an enormous need for more effective targeted therapies to treat cancer at earlier stages, reduce side effects and achieve better, personalised outcomes."

"In the wet tropical regions of the world, malaria is a continuing human catastrophe, with about 2 million fatalities every year and 500,000,000 people suffering debilitating illness. WEHI has made huge strides in understanding this terrible disease, bringing us closer to the day we can bring malaria under control."

"I offer my deepest thanks and congratulations to the Commonwealth and Victorian governments and to philanthropic supporters for their foresight and commitment to Australian medical research."
Further information: Brad Allan, WEHI Communications Manager: tel +61 3 9345 2345; mob 0403036116.

Research Australia

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to